Catalyst Biosciences Inc buy stratec
Start price
08.12.17
/
50%
€3.48
Target price
19.01.18
€8.57
Performance (%)
146.76%
End price
19.01.18
€8.59
Summary
This prediction ended on 19.01.18 with a price of €8.59. With a performance of 146.76% the BUY prediction by stratec was a big success. stratec has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Catalyst Biosciences Inc | - | - | - | - |
| iShares Core DAX® | -1.741% | 5.979% | 8.977% | 49.858% |
| iShares Nasdaq 100 | 2.815% | 11.827% | 38.406% | 100.330% |
| iShares Nikkei 225® | -0.109% | 11.692% | 46.680% | 65.355% |
| iShares S&P 500 | 0.966% | 7.616% | 28.141% | 68.657% |
Comments by stratec for this prediction
In the thread Catalyst Biosciences Inc diskutieren
stratec stimmt der Buy-Einschätzung von melinda zu
stratec stimmt am 08.12.2017 der Buy-Einschätzung von melinda mit dem Kursziel 5,8$ zu.
Überschrift: pharma
- Catalyst Biosciences (NASDAQ:CBIO) initiated with Buy rating and $19 (166% upside) price target by B. Riley FBR.
(Vom Mitglied beendet)